Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs BAL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM BAL PHARMA NGL FINE CHM/
BAL PHARMA
 
P/E (TTM) x 33.7 40.8 82.5% View Chart
P/BV x 5.8 2.3 256.6% View Chart
Dividend Yield % 0.1 1.1 7.6%  

Financials

 NGL FINE CHM   BAL PHARMA
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
BAL PHARMA
Mar-23
NGL FINE CHM/
BAL PHARMA
5-Yr Chart
Click to enlarge
High Rs2,569134 1,915.7%   
Low Rs1,16163 1,831.8%   
Sales per share (Unadj.) Rs450.0193.9 232.1%  
Earnings per share (Unadj.) Rs33.21.7 1,986.9%  
Cash flow per share (Unadj.) Rs51.47.5 686.9%  
Dividends per share (Unadj.) Rs1.751.00 175.0%  
Avg Dividend yield %0.11.0 9.3%  
Book value per share (Unadj.) Rs360.140.7 885.8%  
Shares outstanding (eoy) m6.1815.69 39.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.10.5 813.6%   
Avg P/E ratio x56.259.2 95.0%  
P/CF ratio (eoy) x36.313.2 274.9%  
Price / Book Value ratio x5.22.4 213.2%  
Dividend payout %5.359.9 8.8%   
Avg Mkt Cap Rs m11,5231,549 743.7%   
No. of employees `000NANA-   
Total wages/salary Rs m369553 66.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,7813,042 91.4%  
Other income Rs m559 587.7%   
Total revenues Rs m2,8363,052 92.9%   
Gross profit Rs m350253 138.4%  
Depreciation Rs m11391 123.7%   
Interest Rs m18123 14.9%   
Profit before tax Rs m27447 576.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6921 322.5%   
Profit after tax Rs m20526 782.6%  
Gross profit margin %12.68.3 151.5%  
Effective tax rate %25.144.8 56.0%   
Net profit margin %7.40.9 856.1%  
BALANCE SHEET DATA
Current assets Rs m1,6272,282 71.3%   
Current liabilities Rs m5832,093 27.8%   
Net working cap to sales %37.56.2 606.6%  
Current ratio x2.81.1 256.0%  
Inventory Days Days658 850.8%  
Debtors Days Days8651,128 76.7%  
Net fixed assets Rs m1,244829 150.2%   
Share capital Rs m31157 19.7%   
"Free" reserves Rs m2,195481 456.3%   
Net worth Rs m2,225638 348.9%   
Long term debt Rs m21305 6.8%   
Total assets Rs m2,8713,110 92.3%  
Interest coverage x15.91.4 1,148.9%   
Debt to equity ratio x00.5 1.9%  
Sales to assets ratio x1.01.0 99.0%   
Return on assets %7.84.8 162.0%  
Return on equity %9.24.1 224.3%  
Return on capital %13.018.1 71.8%  
Exports to sales %74.366.4 111.9%   
Imports to sales %9.922.4 44.3%   
Exports (fob) Rs m2,0662,020 102.3%   
Imports (cif) Rs m276683 40.5%   
Fx inflow Rs m2,0952,020 103.7%   
Fx outflow Rs m304716 42.5%   
Net fx Rs m1,7901,305 137.2%   
CASH FLOW
From Operations Rs m353-18 -1,913.6%  
From Investments Rs m-270-222 121.8%  
From Financial Activity Rs m-11244 -4.4%  
Net Cashflow Rs m724 1,921.1%  

Share Holding

Indian Promoters % 73.1 47.1 155.1%  
Foreign collaborators % 0.0 4.2 -  
Indian inst/Mut Fund % 0.0 0.1 30.8%  
FIIs % 0.0 0.1 30.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.9 48.8 55.2%  
Shareholders   16,410 15,060 109.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs BAL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs BAL PHARMA Share Price Performance

Period NGL FINE CHM BAL PHARMA S&P BSE HEALTHCARE
1-Day -0.58% -4.40% 1.18%
1-Month 2.94% -17.76% -0.75%
1-Year 77.47% 40.93% 61.82%
3-Year CAGR 9.82% 19.04% 18.16%
5-Year CAGR 35.36% 5.43% 19.79%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the BAL PHARMA share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 73.1% stake in the company. In case of BAL PHARMA the stake stands at 51.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of BAL PHARMA.

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 5.3%.

BAL PHARMA paid Rs 1.0, and its dividend payout ratio stood at 59.9%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of BAL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.